Comparison of the effects of progesterone and 17 β-estradiol on Schwann cell markers expression in rat adipose-derived stem cells

Document Type: Original Article


1 Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran

2 Department of Anatomy, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Anatomy , Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4 Student Research Committee, Faculty of Dentistry, Kashan University of Medical Sciences, Kashan, Iran


Steroids promote the myelination and regeneration in the peripheral nervous system. Whereas, little is known about the inducing effects by which the hormones exert their effects on Schwann cells differentiation. This could be revealed by the expression of Schwann cell markers in adipose-derived stem cells (ADSCs). The purpose of this study was to present the effects of progesterone and 17 β-estradiol on the Schwann cell markers in rat ADSCs. The mesenchymal stem cell markers (CD73, and CD90) were assayed by flow cytometry. Rat ADSCs were sequentially treated with β-mercaptoethanol, and all-trans-retinoic acid, followed by a mixture of basic fibrobroblast growth factor, platelet-derived growth factor, forskolin and heregulin. In experimental groups, forskolin and heregulin were substituted by progesterone and 17 β-estradiol. After induction, the expression of Schwann cell markers P0, and S-100 and the cellular immunocytochemical staining positive rate of anti-S100 and anti-glial fibrillary acidic protein (GFAP) antibodies were compared in the experimental and control groups. Progesterone and 17 β-estradiol triggered P0 and S-100 genes expression and induced a cellular immunocytochemical staining positive rate of S-100 and GFAP in rats ADSCs. Progesterone induced these changes stronger than 17 β-estradiol. Thus, progesterone may induce rat ADSCs toward Schwann-like cells by expression of Schwann cell markers and is more potent than 17 β-estradiol in the expression of these markers.


Main Subjects

  1. Bunge RP. The role of the Schwann cell in trophic support and regeneration. J Neurol 1994; 242(1): 19-21.
  2. Bhatheja K, Field J. Schwann cells: Origins and role in axonal maintenance and regeneration. Int J Biochem Cell Biol 2006; 38(12): 1995-1999.
  3. Rodriguez FJ, Verdu E, Ceballos D, et al. Nerve guides seeded with autologous Schwann cells improve nerve regeneration. Exp Neurol 2000; 161(2): 571-584.
  4. Rutkowski GE, Miller CA, Jeftinija S, et al. Synergistic effects of micropatterned biodegradable conduits and Schwann cells on sciatic nerve regeneration. J Neural Eng 2004; 1(3): 151-157.
  5. Deng LX, Hu J, Liu N, et al. GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Exp Neurol 2011; 229(2): 238-250.
  6. Ikegame Y, Yamashita K, Hayashi S, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011; 13(6): 675-685.
  7. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-4295.
  8. Kobolak J, Dinnyes A, Memic A, et al. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods 2016; 99: 62-68.
  9. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005; 54(3): 132-141.
  10. Banfi A, Bianchi G, Galotto M, et al. Bone marrow stromal damage after chemo/radiotherapy: Occurrence, consequences and possibilities of treatment. Leuk Lymphoma 2001; 42(5): 863-870.
  11. Muschler GF, Nitto H, Boehm CA, et al. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001; 19(1): 117-125.
  12. Lebeau MC, Jung-Testas I, Baulieu EE. Intracellular distribution of a cytoplasmic progesterone receptor mutant and of immunophilins cyclophilin 40 and FKBP59: Effects of cyclosporin A, of various metabolic inhibitors and of several culture conditions. J Steroid Biochem Mol Biol 1999; 70(4-6): 219-228.
  13. Movaghar B, Tiraihi T, Mesbah-Namin SA. Trans-differentiation of bone marrow stromal cells into Schwann cell phenotype using progesterone as inducer. Brain Res 2008; 1208: 17-24.
  14. Aghajanova L, Horcajadas JA, Esteban FJ, et al. The bone marrow-derived human mesenchymal stem cell: Potential progenitor of the endometrial stromal fibroblast. Biol Reprod 2010; 82(6): 1076-1087.
  15. Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol Lett 2002; 127(1-3): 217-224.
  16. Roglio I, Giatti S, Pesaresi M, et al. Neuroactive steroids and peripheral neuropathy. Brain Res Rev 2008; 57(2): 460-469.
  17. Guennoun R, Benmessahel Y, Delespierre B, et al. Progesterone stimulates Krox-20 gene expression in Schwann cells. Mol Brain Res 2001; 90(1): 75-82.
  18. Schumacher M, Hussain R, Gago N, et al. Progesterone synthesis in the nervous system: Implications for myelination and myelin repair. Front Neurosci 2012; 6: 10.
  19. Koenig HL, Schumacher M, Ferzaz B, et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995; 268(5216): 1500-1503.
  20. Chan JR, Phillips LJ, 2nd, Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc Natl Acad Sci U S A 1998; 95(18): 10459-10464.
  21. Desarnaud F, Do Thi AN, Brown AM, et al. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem 1998; 71(4): 1765-1768.
  22. Arevalo MA, Santos-Galindo M, Bellini MJ, et al. Actions of estrogens on glial cells: Implications for neuro-protection. Biochim Biophys Acta 2010; 1800(10): 1106-1112.
  23. Khanlarkhani N, Atlasi MA, Kashani IR, et al. The effects of progestrone on the in vitro expression of P0, S100 and Krox20 genes in adipose-derived stem cells. Tehran Univ Med J 2011; 69(2): 67-74.
  24. Nejati M, Azami Tameh A, Vahidinia Z, et al. Mesenchymal stem cells improve ischemic stroke injury by anti-inflammatory properties in rat model of middle cerebral artery occlusion. Iran Red Crescent Med J 2018; 20(1): e55085. doi: 10.5812/ircmj.55085.
  25. Golipoor Z, Kashani IR, Akbari M, et al. Differentiation of adipose-derived stem cells into Schwann cell phenotype in comparison with bone marrow stem cells. Iran J Basic Med Sci. 2010; 13(3): 76-84.
  26. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100(9): 1249-1260.
  27. Bunnell BA, Flaat M, Gagliardi C, et al. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008; 45(2): 115-120.
  28. Kingham PJ, Kalbermatten DF, Mahay D, et al. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol 2007; 207(2): 267-274.
  29. Jiang L, Zhu JK, Liu XL, et al. Differentiation of rat adipose tissue-derived stem cells into Schwann-like cells in vitro. Neuroreport 2008; 19(10): 1015-1019.
  30. Yang L, Fang JS, Wang W, et al. Transplantation of Schwann cells differentiated from adipose-derived stem cells modifies reactive gliosis after contusion brain injury in rats. J Int Med Res 2011; 39(4): 1344-1357.
  31. Dezawa M, Takahashi I, Esaki M, et al. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci 2001; 14(11): 1771-1776.
  32. Gao S, Zheng Y, Cai Q, et al. Different methods for inducing adipose-derived stem cells to differentiate into Schwann-like cells. Arch Med Sci 2015; 11(4): 886-892.
  33. Mirsky R, Stewart HJ, Tabernero A, et al. Development and differentiation of Schwann cells. Rev Neurol (Paris) 1996; 152(5): 308-313.
  34. Fuentealba L, Schworer C, Schroering A, et al. Heregulin and forskolin-induced cyclin D3 expression in Schwann cells: Role of a CCAAT promoter element and CCAAT enhancer binding protein. Glia 2004; 45(3): 238-248.
  35. Garratt AN, Britsch S, Birchmeier C. Neuregulin, a factor with many functions in the life of a Schwann cell. Bioessays 2000; 22(11): 987-996.
  36. Jung-Testas I, Schumacher M, Bugnard H, et al. Stimulation of rat Schwann cell proliferation by estradiol: Synergism between the estrogen and cAMP. Brain Res Dev Brain Res 1993; 72(2): 282-290.
  37. Azcoitia I, Leonelli E, Magnaghi V, et al. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol Aging 2003; 24(6): 853-860.
  38. Tanzer L, Jones KJ. Neurotherapeutic action of testosterone on hamster facial nerve regeneration: Temporal window of effects. Horm Behav 2004; 45(5): 339-344.
  39. Balana ME, Labriola L, Salatino M, et al. Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells. Oncogene 2001; 20(1): 34-47.
  40. Melcangi RC, Magnaghi V, Cavarretta I, et al. Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging. Exp Gerontol 1998; 33(7-8): 827-836.
  41. Melcangi RC, Cavarretta IT, Ballabio M, et al. Peripheral nerves: a target for the action of neuroactive steroids. Brain Res Brain Res Rev 2005; 48(2): 328-338.
  42. Zhou S, Zilberman Y, Wassermann K, et al. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem Suppl 2001; Suppl 36: 144-155.
  43. Islamov RR, Hendricks WA, Katwa LC, et al. Effect of 17 beta-estradiol on gene expression in lumbar spinal cord following sciatic nerve crush injury in ovariectomized mice. Brain Res 2003; 966(1): 65-75.
  44. Schumacher M, Guennoun R, Mercier G, et al. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res Brain Res Rev 2001; 37(1-3):343-359.
  45. Strioga M, Viswanathan S, Darinskas A, et al. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 2012; 21(14): 2724-2752.
  46. Elman JS, Li M, Wang F, et al. A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation. J Inflamm (Lond) 2014; 11: 1. doi: 10.1186/1476-9255-11-1
  47. Labriola L, Salatino M, Proietti CJ, et al. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol Cell Biol 2003; 23(3): 1095-1111.